课题基金 / 基金详情

Mitochondrial Protein HSG Is a Major Determinant of Oxid

Mitochondrial Protein HSG Is a Major Determinant of Oxid
线粒体蛋白 HSG 是氧化的主要决定因素
批准号:
7327023
负责人:
Rui-Ping Xiao
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Rui-Ping Xiao的其他基金

相似基金

相关文献

中文摘要
翻译
程序性细胞死亡或细胞凋亡对大多数器官的发育以及成人组织的稳态和重塑都很重要。然而,终末分化心肌细胞的不可避免的损失是导致心力衰竭的一个关键因素,心力衰竭是目前发达国家死亡的主要原因。在这里,我们证明HSG(也称为mitofusin-2),一种线粒体蛋白,是氧化应激介导的心肌细胞凋亡的主要决定因素。心肌梗死通过活性氧(ROS)依赖机制在体内深刻地提高内源性HSG表达和心肌细胞凋亡。同样,H2O2氧化应激同时增加培养大鼠心肌细胞中HSG的表达和凋亡。此外,腺病毒基因转移介导的HSG过表达足以抑制基础和血清刺激的Akt激活,并引发心肌细胞凋亡。通过抑制caspase-9而非caspase-8,以及表达组成型活性PI3K突变体激活Akt或线粒体抗凋亡蛋白Bcl-xL,可完全消除HSG诱导的心肌细胞凋亡,这表明HSG通过抑制PI3K-Akt细胞存活信号并由此激活线粒体主要凋亡途径来促进心肌细胞凋亡。重要的是,sirna介导的HSG沉默可以保护细胞免受氧化应激诱导的凋亡。本研究结果表明,心肌HSG通过抑制原代细胞存活信号Akt,激活线粒体细胞死亡通路,在心肌缺血和氧化应激反应中发挥心肌细胞凋亡的主要决定因素作用。重要的是,心脏HSG表达的增加对于氧化应激诱导的心肌细胞凋亡是必要和充分的,这表明HSG失调可能是心力衰竭的关键致病因素和有希望的治疗靶点。
英文摘要
Programmed cell death, or apoptosis, is important for the development of most organs also for adult tissue homeostasis and remodeling. However, an inexorable loss of terminally differentiated heart muscle cells is a crucial causal factor for heart failure, the current leading cause of death in developed countries. Here, we demonstrate that HSG (also named mitofusin-2), a mitochondria protein, is a major determinant of oxidative stress-mediated cardiomyocyte apoptosis. Myocardial infarction profoundly elevates endogenous HSG expression and myocyte apoptosis in vivo via a reactive oxygen species (ROS)-dependent mechanism. Similarly, oxidative stress with H2O2 concurrently increases HSG expression and apoptosis in cultured rat cardiomyocytes. Furthermore, adenoviral gene transfer-mediated overexpression of HSG is sufficient to suppress both basal and serum-stimulated Akt activation, and triggers robust cardiomyocyte apoptosis. The HSG-induced apoptosis is fully abrogated by inhibition of caspase-9 but not caspase-8, and by expression of a constitutively active PI3K mutant to activate Akt or a mitochondrial antiapoptotic protein, Bcl-xL, indicating that HSG promotes cardiomyocytes apoptosis via inhibition of the PI3K-Akt cell survival signaling and the resultant activation of the primary mitochondrial apoptotic pathway. Importantly, siRNA-mediated HSG silencing protects cells against oxidative stress-induced apoptosis. The present results indicate that cardiac HSG functions as a major determinant of heart muscle cell apoptosis in response to ischemia and oxidative stress, via inhibiting the primary cell survival signal, Akt, resulting in activation of the mitochondrial cell death pathway. Importantly, increased cardiac HSG expression is both necessary and sufficient for oxidative stress-induced heart muscle cell apoptosis, suggesting that HSG deregulation may be a crucial pathogenic element and a promising therapeutic target for heart failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pi3k Gs Signal Control During B2-adrenergic stimulation
  • 批准号:
    6674194
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Rui-Ping Xiao
  • 依托单位:
Intracellular Acidosis-Activated p38 MAPK & Hypoxia
  • 批准号:
    6969624
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Rui-Ping Xiao
  • 依托单位:
CaMKII-dB and CaMKII-dC Oppositely Regulate Cardiomyocyte viability
  • 批准号:
    7591974
  • 项目类别:
  • 资助金额:
    $65.47万
  • 财政年份:
    --
  • 负责人:
    Rui-Ping Xiao
  • 依托单位:
B-Arrestin2 Is Required for BAR Resensitization But Not
  • 批准号:
    7327091
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Rui-Ping Xiao
  • 依托单位:
国内基金
海外基金
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对 话促进子宫腺肌病蜕膜化缺陷的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    吕海宁
  • 依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
  • 批准号:
    32372636
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    郭慧娟
  • 依托单位:
抑制Protein Kinase D促进胚胎干细胞自我更新的分子机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2022
  • 负责人:
    叶守东
  • 依托单位:
C2 DOMAIN PROTEIN 1 (C2DP1)基因家族在植物开花调控中的功能研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2022
  • 负责人:
  • 依托单位: